The effect of molecular weight of drugs on transdermal delivery system using microneedle device

Key Engineering Materials

Volumn 342-343, Issue , 2007, Pages 945-948

  Lee, Chang Rae ^a   Kim, Moon Suk ^b   Lee, Hai Bang ^b   Lee, Han Ku ^c   Rhee, John M ^a   Khang, Gilson ^a  

^a Chonbuk National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c DS and G   (South Korea)

Author keywords

Bufexamac; Insulin; Microneedle system; Molecular weight; OVA; Transdermal system

Indexed keywords

BIOMEDICAL EQUIPMENT; DRUG DELIVERY; INSULIN; MOLECULAR WEIGHT; SKIN;

BUFEXAMAC; MICRONEEDLE SYSTEM; OVA; TRANSDERMAL SYSTEM;

DRUG PRODUCTS;

EID: 34147187339     PISSN: 10139826     EISSN: 16629795     Source Type: Book Series    
DOI: 10.4028/0-87849-436-7.945     Document Type: Conference Paper

References (6)

1. G. Khang, W.Y. Jang, M.S. Kim, H.K. Lee and H.B. Lee: Polymer Sci. Tech., Vol. 16, (2005) p. 486.
2. H.B. Lee and G. Khang, In: High Efficiency Anticancer Drug using Polymeric Biomaterials, Edited by H.B. Lee, Munundang Publishing Co., Seoul (2004)
3. W.Y. Jang, C.R. Lee, S.-M Seo, B. Lee, M.S, Kim, G. Khang, H.G. Lee and H.B, Lee: J. Kor. Pharm. Sci., Vol. 35, (2005) 403.
4. B. Barry and A. Williams: Adv. Drug Deliv. Rev., Vol. 56, (2003), p. 603
5. Y. Kalia and R. Guy: Adv. Drug Deliv. Rev., Vol. 48, (2001), p. 159
6. M.R. Praunsnitz: Adv. Drug Deliv. Rev., Vol. 56, (2004), p. 581